0 results available. Select is focused ,type to refine list, press Down to open the menu,
Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The compan...
The following section summarizes insights on Inozyme Pharma Inc's Shares Outstanding CAGR (3y):
Data is returned as a standard number. Suggested format is percent (e.g 0.171 => 17.1%). Please note, you need a Premium subscription to access data for shares_out_cagr_3y.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Shares Outstanding CAGR (3y) in the valuation category include:
Three-year compound annual growth rate in shares outstanding.